This topic contains a solution. Click here to go to the answer

Author Question: How are NANDA-I problem labels and NOC outcome labels alike? Both describe: a. Health status in ... (Read 39 times)

Sportsfan2111

  • Hero Member
  • *****
  • Posts: 585
How are NANDA-I problem labels and NOC outcome labels alike? Both describe:
 
  a. Health status in terms of human responses
  b. Patient response before interventions are done
  c. Patient response in positive terms
  d. A pattern of related cues

Question 2

Using Maslow's Hierarchy of Needs, rank the following nursing diagnoses in order of importance, beginning with the highest-priority diagnosis. (Enter using the following format: 1, 2, 3, 4)
 
  1) Anxiety
  2) Risk for infection
  3) Disturbed body image
  4) Sleep deprivation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

akemokai

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

ANS: A

Answer to Question 2

ANS:
4, 2, 1, 3




Sportsfan2111

  • Member
  • Posts: 585
Reply 2 on: Jul 22, 2018
Wow, this really help


kalskdjl1212

  • Member
  • Posts: 353
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library